Defining the role of nuclear medicine in haematological tumours-EANM Focus 4: consensus on molecular imaging and therapy in haematological tumours

Affiliations

¹ Nuclear Medicine Unit, IRCCS Azienda Ospitaliero-Universitaria di Bologna, Nuclear Medicine Bld. 30, AOU S. Orsola-Malpighi, Via Massarenti n. 9, 40138, Bologna, Italy. cristina.nanni@aosp.bo.it.
² Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
³ Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
⁴ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.

Editorial

Cristina Nanni et al. Eur J Nucl Med Mol Imaging. 2023 Aug.

. 2023 Aug;50(10):2925-2926.

doi: 10.1007/s00259-023-06276-3.

¹ Nuclear Medicine Unit, IRCCS Azienda Ospitaliero-Universitaria di Bologna, Nuclear Medicine Bld. 30, AOU S. Orsola-Malpighi, Via Massarenti n. 9, 40138, Bologna, Italy. cristina.nanni@aosp.bo.it.
² Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
³ Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
⁴ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.

No abstract available

Comment on

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours.
Nanni C, Kobe C, Baeßler B, Baues C, Boellaard R, Borchmann P, Buck A, Buvat I, Chapuy B, Cheson BD, Chrzan R, Cottereau AS, Dührsen U, Eikenes L, Hutchings M, Jurczak W, Kraeber-Bodéré F, Lopci E, Luminari S, MacLennan S, Mikhaeel NG, Nijland M, Rodríguez-Otero P, Treglia G, Withofs N, Zamagni E, Zinzani PL, Zijlstra JM, Herrmann K, Kunikowska J. Nanni C, et al. Lancet Haematol. 2023 May;10(5):e367-e381. doi: 10.1016/S2352-3026(23)00030-3. Lancet Haematol. 2023. PMID: 37142345

1. Fanti S, Minozzi S, Antoch G, Banks I, et al. Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncol. 2018;19(12):e696–708. https://doi.org/10.1016/S1470-2045(18)30604-1 . - DOI - PubMed
1. Chételat G, Arbizu J, Barthel H, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol. 2020;19(11):951–62. https://doi.org/10.1016/S1474-4422(20)30314-8 . - DOI - PubMed
1. Ambrosini V, Kunikowska J, Baudin E, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021;146:56–73. https://doi.org/10.1016/j.ejca.2021.01.008 . - DOI - PubMed - PMC
1. Nanni C, Kobe C, Baeßler B, et al. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. Lancet Haematol. 2023;10(5):e367–81. https://doi.org/10.1016/S2352-3026(23)00030-3 . - DOI - PubMed